BC3 Technologies featured SEAL Hemostatic Wound Spray during an Amazon Live shopping segment.

Public source

Publisher name

Public post

SEAL Hemostatic Wound Spray was recently featured during an Amazon Live shopping segment, putting emergency preparedness and bleeding control in front of even more consu…

Log in to read the full post

Company

BC3 Technologies

Industry
Biotechnology Research
Location
Baltimore, US
Company size
2–10 employees

About BC3 Technologies

BC3 Technologies (BC3T, focus is on developing novel and effective antihemorrhagic products for the medical, military, and general consumer sectors. BC3T’s proprietary chitosan-based aerosol product allows ease of application on wounds as well high-clotting ability which rivals against competitors’ products in both performance and cost. The biggest differentiator for BC3T’s technology compared to others is that the chitosan-based product has maximized hemostatic activity, great stability, and wide-range of applications.

See more

Latest activity

5 signals

Discover more

Similar public activity from other companies.

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

© 2026 SeedOpsCompany intelligence.

SeedOps.